Phase II study of intravenously infused pazufloxacin mesilate

Kousei Shimada, M. Matuda, Shoichiro Irimajiri, Hiroshi Oshitani, Nozomu Kobayashi(National Cancer Center Hospital East), K. Kudo, Mitsuhide Ohmichi, Tomoatsu Nakamura, Yuichiro Matsuoka(Kumamoto Orthopedic Surgery Hospital), O Kunii, Haruhito Hirano, Harumi Shishido, Yuka Kawakami, Tomoya Imai(Kyoto University), Y. Sugama, K. Konishi, Keiko Suzuki(Astellas Pharma (Japan)), H. Kobayashi, Ken Takeuchi, Isami Hayashi(Kyorin University), Masaya Baba(Fujirebio (Japan)), Hisa Nishiya, Hiroyasu Inoue(University of the Sciences), Motomichi Koyama, Yuji Nishiura, Seiichi Kitamura, N. Koido, K. Okada, Yoshihiro Hirai, Satoko Hori(Keio University), Y. Hiraga, A. Watanabe, Yamato Sano, Kazunobu Sato(Osaka City University), Yasutoshi Suzuki(Tokyo University of Technology), Takashi Inamatsu, O Sekine, S. Kawai, Shiro Oka(Kyoto University), A Kurashima, I. Sakurai, Eiichi Yamaguchi, Shosaku Abe(Sapporo Medical University), T. Nukiwa(Tohoku University), Tomofumi Igarashi(National Cancer Center Hospital East), S. Odagiri, J. Shimada, Y. Arai(High Energy Accelerator Research Organization), F. Matsumoto, Kohya Shiba
Unknown
January 1, 1999
Cited by 0


Related Papers